Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia.
Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Research Abstract Details
Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Publishing Authors By Initials
Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Journal Published:
PUBLICATION TYPE: Letter
Journal: Pediatric blood & cancer
VOLUME: 50
Page Numbers: 189
Journal Abbreviation:
ISSN: 1545-5017
DAY: 26
MONTH: Jan
YEAR: 2008
Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 101186624
Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia.
AFFILIATION:
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Pediatr Blood Cancer
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia Related Publications